Gene · 6921
Papers1,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 1,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PD-1/PD-L1 inhibitors-based treatment for advanced renal cell carcinoma: Mechanisms affecting efficacy and combination therapies. | Cancer Med | 2021 | 34382349 | PubTator, text mining | PubMed |
| Integrative oncogene-dependency mapping identifies RIT1 vulnerabilities and synergies in lung cancer. | Nat Commun | 2021 | 34373451 | PubTator, text mining | PubMed |
| Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs. | Int J Mol Sci | 2021 | 34360679 | PubTator, text mining | PubMed |
| The Most Common VHL Point Mutation R167Q in Hereditary VHL Disease Interferes with Cell Plasticity Regulation. | Cancers (Basel) | 2021 | 34359798 | PubTator, text mining | PubMed |
| Increased modularity of the resting-state network in children with nonsyndromic cleft lip and palate after speech rehabilitation. | Brain Behav | 2021 | 34343416 | PubTator, text mining | PubMed |
| A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection. | Mol Syst Biol | 2021 | 34339582 | PubTator, text mining | PubMed |
| SHARPIN regulates the development of clear cell renal cell carcinoma by promoting von Hippel-Lindau protein ubiquitination and degradation. | Cancer Sci | 2021 | 34339558 | PubTator, text mining | PubMed |
| Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro. | Med Oncol | 2021 | 34331598 | PubTator, text mining | PubMed |
| Histone deacetylase inhibitor induced pVHL-independent degradation of HIF-1α and hierarchical quality control of pVHL via chaperone system. | PLoS One | 2021 | 34329303 | PubTator, text mining | PubMed |
| Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis. | Oncogene | 2021 | 34321604 | PubTator, text mining | PubMed |
| Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling. | Acta Neuropathol | 2021 | 34302498 | PubTator, text mining | PubMed |
| STAT5 as a Key Protein of Erythropoietin Signalization. | Int J Mol Sci | 2021 | 34281163 | PubTator, text mining | PubMed |
| Tai Chi Chuan Alters Brain Functional Network Plasticity and Promotes Cognitive Flexibility. | Front Psychol | 2021 | 34267705 | PubTator, text mining | PubMed |
| Diffuse white matter abnormality in very preterm infants at term reflects reduced brain network efficiency. | Neuroimage Clin | 2021 | 34237685 | PubTator, text mining | PubMed |
| Within node connectivity changes, not simply edge changes, influence graph theory measures in functional connectivity studies of the brain. | Neuroimage | 2021 | 34224851 | PubTator, text mining | PubMed |
| Distinct MicroRNA Profiles in the Perilymph and Serum of Patients With Menière's Disease. | Front Neurol | 2021 | 34220670 | PubTator, text mining | PubMed |
| Molecular Insights into the Oxygen-Sensing Pathway and Erythropoietin Expression Regulation in Erythropoiesis. | Int J Mol Sci | 2021 | 34209205 | PubTator, text mining | PubMed |
| Regulation of Cancer Metabolism by Deubiquitinating Enzymes: The Warburg Effect. | Int J Mol Sci | 2021 | 34201062 | PubTator, text mining | PubMed |
| Examination of the APOBEC3 Barrier to Cross Species Transmission of Primate Lentiviruses. | Viruses | 2021 | 34200141 | PubTator, text mining | PubMed |
| Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. | Environ Int | 2021 | 34186270 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6921/papers?page=23